The Somatic Genomic Landscape of Glioblastoma

Brennan, Cameron W., Verhaak, Roel G.W., McKenna, Aaron, Campos, Benito, Noushmehr, Houtan, Salama, Sofie R., Zheng, Siyuan, Chakravarty, Debyani +292 more·2013·Cell

DOI 10.1016/j.cell.2013.09.034

Cited by (1,018)

Items 101–200 of 1,018

Challenges and Opportunities in Cancer Drug Resistance
Richard A. Ward, Stephen E. Fawell, Nicolas Floc’h, Vikki Flemington, Darren McKerrecher, Paul D. Smith · 2020 · Chemical Reviews
Brain malignancies: Glioblastoma and brain metastases
Tamara T. Lah, Metka Novak, Barbara Breznik · 2019 · Seminars in Cancer Biology
Glioblastoma targeted therapy: updated approaches from recent biological insights
Mehdi Touat, Ahmed Idbaïh, Marc Sanson, Keith Lloyd Ligon · 2017 · Annals of Oncology
Immune Microenvironment in Glioblastoma Subtypes
Zhihong Chen, Dolores Hambardzumyan · 2018 · Frontiers in Immunology
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz, Kristen Fousek, Tiara T. Byrd, Heba Samaha, Malini Mukherjee, Nikita Aware, Meng-Fen Wu, Jordan Scott Orange, Pavel Sumazin, Tsz‐Kwong Man et al. · 2017 · Neuro-Oncology
Primary brain tumours in adults
Martin J. van den Bent, Marjolein Geurts, Pim J. French, Marion Smits, David Capper, Jacoline E. C. Bromberg, Susan Marina Chang · 2023 · The Lancet
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Fatima Khan, Lizhi Pang, Madeline Dunterman, Maciej S. Lesniak, Amy B. Heimberger, Peiwen Chen · 2023 · Journal of Clinical Investigation
Genetically engineered cerebral organoids model brain tumor formation
Shan Bian, Marko Repic, Zhenming Guo, Anoop Murthy Kavirayani, Thomas Rainer Burkard, Joshua A. Bagley, Christian Krauditsch, Juergen A. Knoblich · 2018 · Nature Methods
Mitochondrial control by DRP1 in brain tumor initiating cells
Qi Xie, Qiulian Wu, Craig Horbinski, William A. Flavahan, Kailin Yang, Wenchao Zhou, Stephen M. Dombrowski, Zhi Huang, Xiaoguang Fang, Yu Shi et al. · 2015 · Nature Neuroscience
The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells
Deobrat Dixit, Briana C. Prager, Ryan C. Gimple, Hui Xian Poh, Yang Wang, Qiulian Wu, Zhixin Qiu, Reilly L. Kidwell, Leo J.Y. Kim, Qi Xie et al. · 2020 · Cancer Discovery
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
Kim, Hoon, Zheng, Siyuan, Amini, Seyed S., Virk, Selene M., Mikkelsen, Tom, Brat, Daniel J., Grimsby, Jonna, Sougnez, Carrie, Muller, Florian, Hu, Jian et al. · 2015 · Genome Research
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
Maleeha A. Qazi, Parvez Vora, Chitra Venugopal, Sachdev S. Sidhu, Jason Moffat, Charles Swanton, Sheila Kumari Singh · 2017 · Annals of Oncology
Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1
Frank Szulzewsky, Andreas Pelz, Xi Feng, Michael Synowitz, Darko S. Markovic, Thomas Langmann, Inge R. Holtman, Xi Wang, Bart J. L. Eggen, H. W. G. M. Boddeke et al. · 2015 · PLoS ONE
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Xiaoyang Lan, David J. Jörg, Florence M.G. Cavalli, Laura M. Richards, Long V. Nguyen, Robert J. Vanner, Paul Guilhamon, Lilian Lee, Michelle M. Kushida, Davide Pellacani et al. · 2017 · Nature
Mechanisms of PTEN loss in cancer: It’s all about diversity
Virginia Alvarez Garcia, Yasmine Tawil, Helen M. Wise, Nicholas R. Leslie · 2019 · Seminars in Cancer Biology
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka Amankulor, Youngmi Kim, Sonali Arora, Julia Kargl, Frank Szulzewsky, Mark L. Hanke, Daciana H. Margineantu, Aparna Rao, Hamid Bolouri, Jeff J. Delrow et al. · 2017 · Genes & Development
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
Ibrahim A. Qaddoumi, Wilda Orisme, Ji Wen, Teresa Santiago, Kirti Gupta, James Dalton, Bo Tang, Kelly Haupfear, Chandanamali Punchihewa, John B. Easton et al. · 2016 · Acta Neuropathologica
Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence
Gabriele Sulli, Amy Rommel, Xiaojie Wang, Matthew J. Kolar, Francesca Puca, Alan Saghatelian, Maksim V. Plikus, Inder M. Verma, Satchidananda Panda · 2018 · Nature
Federated learning enables big data for rare cancer boundary detection
Pati, Sarthak, Baid, Ujjwal, Edwards, Brandon, Sheller, Micah, Wang, Shih-Han, Reina, G. Anthony, Foley, Patrick, Gruzdev, Alexey, Karkada, Deepthi, Davatzikos, Christos et al. · 2022 · Nature Communications
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
Lyons, Jonathan J, Yu, Xiaomin, Hughes, Jason D, Le, Quang T, Jamil, Ali, Bai, Yun, Ho, Nancy, Zhao, Ming, Liu, Yihui, O'Connell, Michael P et al. · 2016 · Nature Genetics
Glioblastoma Stem Cells: Driving Resilience through Chaos
Briana C. Prager, Shruti Bhargava, Vaidehi Mahadev, Christopher G. Hubert, Jeremy N. Rich · 2020 · Trends in cancer
Critical limitations of consensus clustering in class discovery
Yasin Şenbabaoğlu, George C. Michailidis, Jun Z. Li · 2014 · Scientific Reports
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting
Kiyoung Eun, Seok Won Ham, Hyunggee Kim · 2017 · BMB Reports
Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression
Yekaterina A. Miroshnikova, Janna K. Mouw, James Matthew Barnes, Michael W. Pickup, Johnathan N. Lakins, Youngmi Kim, Khadjia A. Lobo, Anders I. Persson, Gerald F. Reis, Tracy Richmond McKnight et al. · 2016 · Nature Cell Biology
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer, Jüri Reimand, Xiaoyang Lan, Renee Head, Xueming Zhu, Michelle M. Kushida, Jane Bayani, Jessica C. Pressey, Anath Christopher Lionel, Ian D. Clarke et al. · 2015 · Proceedings of the National Academy of Sciences
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
Xun Jin, Leo J.Y. Kim, Qiulian Wu, Lisa C. Wallace, Briana C. Prager, Tanwarat Sanvoranart, Ryan C Gimple, Xiuxing Wang, Stephen C. Mack, Tyler E. Miller et al. · 2017 · Nature Medicine
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
Paolo Maria Comoglio, Livio Trusolino, Carla Boccaccio · 2018 · Nature reviews. Cancer
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
Frank B. Furnari, Timothy Francis Cloughesy, Webster K. Cavenee, Paul S. Mischel · 2015 · Nature reviews. Cancer
Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling
Xinya Gao, Xin Xia, Fanying Li, Maolei Zhang, Huangkai Zhou, Xujia Wu, Jian Zhong, Zheng Zhao, Kun Zhao, Dawei Liu et al. · 2021 · Nature Cell Biology
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, Attila A. · 2024 · International Journal of Molecular Sciences
Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system
Simon Gritsch, Tracy T. Batchelor, L. Nicolas Gonzalez Castro · 2021 · Cancer
Sex differences in cancer mechanisms
Joshua B. Rubin, Joseph S. Lagas, Lauren Broestl, Jasmin Sponagel, Nathan Rockwell, Gina Rhee, Sarah F. Rosen, Si Chen, Robyn S. Klein, P. I. Imoukhuede et al. · 2020 · Biology of Sex Differences
Multiplexed Profiling of Single Extracellular Vesicles
Kyungheon Lee, Kyle B. Fraser, Bassel Ghaddar, Katy S. Yang, Eunha Kim, Leonora Balaj, Ennio Antonio Chiocca, Xandra O. Breakefield, Hakho Lee, Ralph Weissleder · 2017 · ACS Nano
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Chris Jones, Matthias A. Karajannis, David Jones, Mark W. Kieran, Michelle Monje, Suzanne J. Baker, Oren Josh Becher, Yoon‐Jae Cho, Nalin M. Gupta, Cynthia E Hawkins et al. · 2016 · Neuro-Oncology
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Ester Gangoso, Benjamin Southgate, Leanne Bradley, Stefanie Lehr, Felipe Gálvez‐Cancino, Niamh McGivern, Esra Güç, Chantriolnt-Andreas Kapourani, Adam Byron, Kirsty M. Ferguson et al. · 2021 · Cell
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
Michael D. Iglesia, Joel S. Parker, Katherine A. Hoadley, Jonathan Stuart Serody, Charles M. Perou, Benjamin Garrett Vincent · 2016 · JNCI Journal of the National Cancer Institute
Long Noncoding RNA NEAT1 , Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/ β -Catenin Pathway by Scaffolding EZH2
Qun Chen, Jinquan Cai, Qixue Wang, Yunfei Wang, Mingyang Liu, Jingxuan Yang, Junhu Zhou, Chunsheng Kang, Min Li, Chuanlu Jiang · 2017 · Clinical Cancer Research
Cell-Cycle Therapeutics Come of Age
Matthew A. Ingham, Gary K. Schwartz · 2017 · Journal of Clinical Oncology
A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1
Xin Xia, Xixi Li, Fanying Li, Xujia Wu, Maolei Zhang, Huangkai Zhou, Nunu Huang, Xuesong Yang, Feizhe Xiao, Dawei Liu et al. · 2019 · Molecular Cancer
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment
Jia Di, Shenglan Li, Dali Li, Haipeng Xue, Dan Yang, Ying Liu · 2018 · Aging
Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets
Junfeng Bi, Sudhir Chowdhry, Sihan Wu, Wenjing Zhang, Kenta Masui, Paul S. Mischel · 2019 · Nature reviews. Cancer
BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study
Thomas Joseph Kaley, Mehdi Touat, Vivek Subbiah, Antoine Hollebecque, Jordi Ahnert Rodon, Albert Craig Lockhart, Vicki Leigh Keedy, Franck Bielle, Ralf‐Dieter Hofheinz, Florence Joly et al. · 2018 · Journal of Clinical Oncology
The landscape of the mesenchymal signature in brain tumours
Jinan Behnan, Gaetano Finocchiaro, Gabi Hanna · 2019 · Brain
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma
Priya Kumthekar, Caroline H. Ko, Tatjana Paunesku, Karan Dixit, Adam M. Sonabend, Orin G. Bloch, Matthew C. Tate, Margaret A. Schwartz, Laura Zuckerman, Ray Lezon et al. · 2021 · Science Translational Medicine
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Andrey Korshunov, Marina Vladimirovna Ryzhova, Volker Hovestadt, Sebastian Bender, Dominik Sturm, David Capper, Jochen Meyer, Daniel Schrimpf, Marcel Kool, Paul A. Northcott et al. · 2015 · Acta Neuropathologica
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
Huimin Hu, Quanhua Mu, Zhaoshi Bao, Yiyun Chen, Yanwei Liu, Jing Chen, Kuanyu Wang, Zheng Wang, Yoonhee Nam, Biaobin Jiang et al. · 2018 · Cell
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
Syreeta DeCordova, Abhishek Shastri, Anthony George Tsolaki, Hadida Yasmin, Lukas Klein, Shiv K. Singh, Uday Kishore · 2020 · Frontiers in Immunology
Targeting cellular pathways in glioblastoma multiforme
Joshua R. D. Pearson, Tarik Regad · 2017 · Signal Transduction and Targeted Therapy
Functional Enhancers Shape Extrachromosomal Oncogene Amplifications
Andrew R. Morton, Nergiz Dogan-Artun, Zachary J. Faber, Graham Dickson and Hugh MacLeod, Cynthia F. Bartels, Megan S. Piazza, Kevin Cameron Allan, Stephen C. Mack, Xiuxing Wang, Ryan C. Gimple et al. · 2019 · Cell
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba A. Ali, Justin Durla Lathia, Peiwen Chen · 2024 · Cellular and Molecular Immunology
Prognostic and Predictive Biomarkers in Gliomas
Paulina Śledzińska, Marek G. Bebyn, Jacek Furtak, Janusz Kowalewski, Marzena Anna Lewandowska · 2021 · International Journal of Molecular Sciences
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity
Elanor N. Wainwright, Paola Scaffidi · 2017 · Trends in Cancer
Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma
Peiwen Chen, Di Zhao, Jun Li, Xin Liang, Jiexi Li, Andrew H. Chang, Verlene K. Henry, Zhengdao Lan, Denise J. Spring, Ganesh Rao et al. · 2019 · Cancer Cell
Increased global transcription activity as a mechanism of replication stress in cancer
Panagiotis Kotsantis, Lara Marques Silva, Sarah Irmscher, Rebecca M. Jones, Lisa K. Folkes, Natalia Gromak, Eva Petermann · 2016 · Nature Communications
Onco-Multi-OMICS Approach: A New Frontier in Cancer Research
Sajib Chakraborty, Md. Ismail Hosen, Musaddeque Ahmed, Hossain Uddin Shekhar · 2018 · BioMed Research International
Advances in local therapy for glioblastoma — taking the fight to the tumour
Thomas S. van Solinge, Lisa Nieland, Ennio Antonio Chiocca, Marike L. D. Broekman · 2022 · Nature Reviews Neurology
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Johanna Klughammer, Barbara Kiesel, Thomas Roetzer-Pejrimovsky, Nikolaus Fortelny, Amelie Nemc, Karl‐Heinz Nenning, Julia Furtner, Nathan C. Sheffield, Paul Datlinger, Nadine Peter et al. · 2018 · Nature Medicine
The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
Yuan Xie, Tobias Bergström, Yiwen Jiang, Patrik Johansson, Voichita Dana Marinescu, Nanna Lindberg, Anna Segerman, Grzegorz Wicher, Mia Niklasson, Sathishkumar Baskaran et al. · 2015 · EBioMedicine
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
Genaro R. Villa, Jonathan J. Hulce, Ciro Zanca, Junfeng Bi, Shiro Ikegami, Gabrielle L. Cahill, Yuchao Gu, Kenneth M. Lum, Kenta Masui, Huijun Yang et al. · 2016 · Cancer Cell
MET-dependent solid tumours — molecular diagnosis and targeted therapy
Robin Guo, Jia Luo, Jason C. Chang, Natasha Rekhtman, Maria E. Arcila, Alexander Edward Dela Cruz Drilon · 2020 · Nature Reviews Clinical Oncology
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Ymke van der Pol, Florent C. Mouliere · 2019 · Cancer Cell
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Olivia G. Taylor, Joshua S. Brzozowski, Kathryn Anne Skelding · 2019 · Frontiers in Oncology
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
Wojciech Szopa, Thomas A. Burley, Gabriela Krämer-Marek, Wojciech Kaspera · 2017 · BioMed Research International
The Role of Hypoxia in Glioblastoma Invasion
Ana Rita Monteiro, Richard Hill, Geoffrey John Pilkington, Patrícia A. Madureira · 2017 · Cells
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma
Ana C. deCarvalho, Hoon Kim, Laila Poisson, Mary E. Winn, Claudius Mueller, David Cherba, Julie M. Koeman, Sahil Seth, Alexei I. Protopopov, Michelle Madden Felicella et al. · 2018 · Nature Genetics
Spatiotemporal Evolution of the Primary Glioblastoma Genome
Jinkuk Kim, In‐Hee Lee, Hee Jin Cho, Chul‐Kee Park, Yang-Soon Jung, Yanghee Kim, So Hee Nam, Byung Sup Kim, Mark D. Johnson, Doo‐Sik Kong et al. · 2015 · Cancer Cell
EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
Runping Fang, Xin Chen, Sicong Zhang, Hui Shi, Youqiong Ye, Hailing Shi, Zhongyu Zou, Peng Li, Qing Guo, Li Ma et al. · 2021 · Nature Communications
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
Laura M. Richards, Owen Whitley, Graham Dickson and Hugh MacLeod, Florence M.G. Cavalli, Fiona J. Coutinho, Julia E. Jaramillo, Nataliia Svergun, Mazdak Riverin, Danielle C. Croucher, Michelle M. Kushida et al. · 2021 · Nature Cancer
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
Eskil Eskilsson, Gro Vatne Røsland, Gergely Morten Solecki, Qianghu Wang, Patrick N. Harter, Grazia Graziani, Roel G.W. Verhaak, Frank Winkler, Rolf Bjerkvig, Hrvoje Miletić · 2017 · Neuro-Oncology
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
Tathiane Maistro Malta, Camila Ferreira de Souza, Thaís S. Sabedot, Tiago C. Silva, Maritza S. Mosella, Steven N. Kalkanis, James Snyder, Ana Valeria B. Castro, Houtan Noushmehr · 2017 · Neuro-Oncology
Glioblastoma at the crossroads: current understanding and future therapeutic horizons
Shilpi Singh, Devanjan Dey, Debashis Barik, Iteeshree Mohapatra, Stefan Kim, Mayur Sharma, Sujata Prasad, Peize Wang, Amar Ranjan Singh, Gatikrushna Singh · 2025 · Signal Transduction and Targeted Therapy
The NF1 somatic mutational landscape in sporadic human cancers
Charlotte Philpott, Hannah Tovell, Ian M. Frayling, D.N. Cooper, Meena Upadhyaya · 2017 · Human Genomics
Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis
Michael T. C. Poon, Cathie L. M. Sudlow, Jonine D. Figueroa, Paul Martin Brennan · 2020 · Scientific Reports
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas
Tamar R. Berger, Patrick Yung Wen, Melanie Lang‐Orsini, Ugonma Nnenna Chukwueke · 2022 · JAMA Oncology
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Anna Galstyan, Janet L. Markman, Ekaterina S. Shatalova, Antonella Chiechi, Alan J. Korman, Rameshwar Patil, Dmytro Klymyshyn, Warren G. Tourtellotte, Liron Limor Israel, Oliver Braubach et al. · 2019 · Nature Communications
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Chris Jones, Suzanne J. Baker · 2014 · Nature reviews. Cancer
ROS1-dependent cancers — biology, diagnostics and therapeutics
Alexander Edward Dela Cruz Drilon, Chelsea Jenkins, Sudarshan R. Iyer, Adam Jacob Schoenfeld, Clare Keddy, Monika Ashok Davare · 2020 · Nature Reviews Clinical Oncology
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
Marc Zuckermann, Volker Hovestadt, Christiane Brigitte Knobbe-Thomsen, Marc Zapatka, Paul A. Northcott, Kathrin Schramm, Jelena Belic, David Jones, Barbara R. Tschida, Branden S. Moriarity et al. · 2015 · Nature Communications
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Francis Cloughesy, Olivier Louis Chinot, Wolfgang Wick, Ryo Nishikawa, Warren P. Mason, Roger Henriksson et al. · 2015 · Journal of Clinical Oncology
Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
Alan T. Yeo, Shruti Rawal, Bethany Delcuze, Anthos Christofides, Agata M. P. Atayde, Laura Strauss, Leonora Balaj, Vaughn A. Rogers, Erik J. Uhlmann, Hemant Varma et al. · 2022 · Nature Immunology
When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma
Saskia Roesch, Carmen Rapp, Steffen Dettling, Christel C. Herold‐Mende · 2018 · International Journal of Molecular Sciences
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Brenda Auffinger, Drew A. Spencer, Peter Pytel, Atique U. Ahmed, Maciej S. Lesniak · 2015 · Expert Review of Neurotherapeutics
Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
Sameer Agnihotri, Gelareh Mohammed Zadeh · 2015 · Neuro-Oncology
<i>EGFR</i> Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
Francis, Joshua M., Zhang, Cheng-Zhong, Maire, Cecile L., Jung, Joonil, Manzo, Veronica E., Adalsteinsson, Viktor A., Homer, Heather, Haidar, Sam, Blumenstiel, Brendan, Pedamallu, Chandra Sekhar et al. · 2014 · Cancer Discovery
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano, Alessandra Fucci, Veroniquè Frattini, Marianne Labussière, Karima Mokhtari, Pietro Zoppoli, Yannick Marie, Aurélie Bruno, Blandine Boisselier, Marine Giry et al. · 2015 · Clinical Cancer Research
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
Sabine Hombach‐Klonisch, Maryam Mehrpour, Shahla Shojaei, Craig Henry Harlos, Marshall W. Pitz, Ahmed Hamaï, Krzysztof Siemianowicz, Wirginia Likus, Emilia Wiecheć, Brian D. Toyota et al. · 2017 · Pharmacology & Therapeutics
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
Aoki, Kosuke, Nakamura, Hideo, Suzuki, Hiromichi, Matsuo, Keitaro, Kataoka, Keisuke, Shimamura, Teppei, Motomura, Kazuya, Ohka, Fumiharu, Shiina, Satoshi, Yamamoto, Takashi et al. · 2018 · Neuro-Oncology
BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
Matthew Mistry, Nataliya Zhukova, Daniele Merico, Patricia Rakopoulos, Rahul Krishnatry, Mary Shago, James Stavropoulos, Noa Alon, Jason D. Pole, Peter N. Ray et al. · 2015 · Journal of Clinical Oncology
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types
Nils Johan Fredriksson, Lars Ny, Jonas A. Nilsson, Erik Larsson · 2014 · Nature Genetics
Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression
Wang, Xiuxing, Prager, Briana C., Wu, Qiulian, Kim, Leo J.Y., Gimple, Ryan C., Shi, Yu, Yang, Kailin, Morton, Andrew R., Zhou, Wenchao, Zhu, Zhe et al. · 2018 · Cell Stem Cell
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Zhen Dong, Guoxin Zhang, Meng Qu, Ryan C. Gimple, Qiulian Wu, Zhixin Qiu, Briana C. Prager, Xiuxing Wang, Leo J.Y. Kim, Andrew R. Morton et al. · 2019 · Cancer Discovery
Isocitrate dehydrogenase mutations in gliomas
Matthew S. Waitkus, Bill H. Diplas, Hai Yan · 2015 · Neuro-Oncology
Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies
Ashkan Pouyan, Masoud Ghorbanlo, Masoud Eslami, Majid Jahanshahi, Ehsan Ziaei, Ali Salami, Khatere Mokhtari, Koorosh Shahpasand, Najma Farahani, Tohid Emami Meybodi et al. · 2025 · Molecular Cancer
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants
Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu, Anu Gupta, Cynthia B. Leary, Scott Wise, Thomas J. Rutkoski, Yu Mi Ahn, Gada Al-Ani, Stacie L. Bulfer et al. · 2019 · Cancer Cell
Spatiotemporal genomic architecture informs precision oncology in glioblastoma
Jin‐Ku Lee, Jiguang Wang, Jason K. Sa, Erik Ladewig, Hae‐Ock Lee, In‐Hee Lee, Hyun Ju Kang, Daniel I. S. Rosenbloom, Pablo G. Cámara, Zhaoqi Liu et al. · 2017 · Nature Genetics
Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
Alessio D’Alessio, Gabriella Proietti, Gigliola Sica, Bianca Maria Scicchitano · 2019 · Cancers
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
Baoli Hu, Qianghu Wang, Yanru Wang, Sujun Hua, Charles-Etienne Gabriel Sauvé, Derrick Sek Tong Ong, Zheng D. Lan, Qing Chang, Yan Wing Ho, Marta Moreno Monasterio et al. · 2016 · Cell
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
Garg, Abhishek D., Vandenberk, Lien, Koks, Carolien, Verschuere, Tina, Boon, Louis, Van Gool, Stefaan W., Agostinis, Patrizia · 2016 · Science Translational Medicine
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma
Hoogstrate, Youri, Draaisma, Kaspar, Ghisai, Santoesha A., van Hijfte, Levi, Barin, Nastaran, de Heer, Iris, Coppieters, Wouter, van den Bosch, Thierry P.P., Bolleboom, Anne, Gao, Zhenyu et al. · 2023 · Cancer Cell
Molecular Mechanisms of Treatment Resistance in Glioblastoma
Alexander C. Ou, W.K. Alfred Yung, Nazanin Majd · 2020 · International Journal of Molecular Sciences